Disulfide bond bridged divalent antibody-toxin, (Fab-PE38fl)2, with the toxin PE38 fused to the light chain

Journal of Microbiology and Biotechnology

Volumn 18, Issue 8, 2008, Pages 1475-1481

  Won, Jae Seon ^a   Choe, Mu Hyeon ^a  

^a Korea University   (South Korea)

Author keywords

Antibody refolding; Cytotoxicity; Divalent antibody toxin; Homodimer; Light chain toxin fusion; Pseudomonas exotoxin A

Indexed keywords

CYSTEINE; HOMODIMER; IMMUNOGLOBULIN F(AB')1 FRAGMENT; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN F(AB')3 FRAGMENT; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN LIGHT CHAIN; PSEUDOMONAS EXOTOXIN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ARTICLE; CANCER CELL; CELL STRAIN MCF 7; DISULFIDE BOND; DRUG CYTOTOXICITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN FOLDING; PSEUDOMONAS;

ANTIBODIES, MONOCLONAL; BACTERIAL PROTEINS; BIOTECHNOLOGY; BREAST NEOPLASMS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; DISULFIDES; ESCHERICHIA COLI; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOTOXINS; LEWIS BLOOD-GROUP SYSTEM; PLASMIDS; PROTEIN FOLDING; RECOMBINANT FUSION PROTEINS;

PSEUDOMONAS EXOTOXIN;

EID: 56749176169     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Allured, V. S., R. J. Collier, S. F. Carroll, and D. B. McKay. 1986. Structure of exotoxin A of Pseudomonas aeruginosa at 3.0 Angstrom. Proc. Natl. Acad. Sci. USA 83: 1320-1324.
2. Benhar, I. and I. Pastan. 1995. Characterization of B1(Fv)PE38 and B1(dsFv)PE38: Single-chain and disulfide-stabilized Fv immunotoxins with increased activity that cause complete remissions of established human carcinoma xenografts in nude mice. Clin. Cancer Res. 1: 1023-1029.
3. Brinkmann, U., J. Buchner, and I. Pastan. 1992. Independent domain folding of Pseudomonas exotoxin and single-chain immunotoxins: Influence of interdomain connections. Proc. Natl. Acad. Sci. USA 89: 3075-3079.
4. Brinkmann, U., L. H. Pai, D. J. FitzGerald, M. Willingham, and I. Pastan. 1991. B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice. Proc. Natl. Acad. Sci. USA 88: 8616-8620.
5. Buchner, J., I. Pastan, and U. Brinkmann. 1992. A method for increasing the yield of properly folded recombinant fusion proteins: Single-chain immunotoxins from renaturation of bacterial inclusion bodies. Anal. Biochem. 205: 263-270.
6. Buchner, J. and R. Rudolph. 1991. Renaturation, purification and characterization of recombinant Fab-fragments produced in Escherichia coli. Biotechnology (NY) 9: 157-162.
7. Choe, M., K. O. Webber, and I. Pastan. 1994. B3(Fab)-PE38M: A recombinant immunotoxin in which a mutant form of Pseudomonas exotoxin is fused to the Fab fragment of monoclonal antibody B3. Cancer Res. 54: 3460-3467.
8. Choi, S. H., J. E. Kim, Y. C. Lee, Y. J. Jang, I. Pastan, and M. H. Choe. 2001. A divalent immunotoxin formed by the disulfide bond between hinge regions of Fab domain. Bull. Kor. Chem. Soc. 22: 1361-1365.
9. Colcher, D., R. Bird, M. Roselli, K. D. Hardman, S. Johnson, S. Pope, et al. 1990. In vivo tumor targeting of a recombinant single-chain antigen-binding protein. J. Natl. Cancer Inst. 82: 1191-1197.
10. Derocq, J. M., P. Casellas, G. Laurent, S. Ravel, H. Vidal, and F. Jansen. 1988. Comparison of the cytotoxic potency of T101 Fab, F(ab')2 and whole IgG immunotoxins. J. Immunol. 141: 2837-2843.
11. Horio, M., E. Lovelace, I. Pastan, and M. M. Gottesman. 1991. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles. Biochim. Biophys. Acta 1061: 106-110.
12. Hwang, J., D. J. FitzGerald, S. Adhya, and I. Pastan. 1987. Functional domains of Pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli. Cell 48: 129-136.
13. Kreitman, R. J., C. N. Chang, D. V. Hudson, C. Queen, P. Bailon, and I. Pastan. 1994. Anti-Tac(Fab)-PE40, a recombinant double-chain immunotoxin which kills interleukin-2-receptor-bearing cells and induces complete remission in an in vivo tumor model. Int. J. Cancer 57: 856-864.
14. Onda, M., Q. C. Wang, H. F. Guo, N. K. Cheung, and I. Pastan. 2004. In vitro and in vivo cytotoxic activities of recombinant immunotoxin 8H9(Fv)-PE38 against breast cancer, osteosarcoma, and neuroblastoma. Cancer Res. 64: 1419-1424.
15. Pai, L. H., J. K. Batra, D. J. FitzGerald, M. C. Willingham, and I. Pastan. 1991. Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin. Proc. Natl. Acad. Sci. USA 88: 3358-3362.
16. Park, J. H., H. W. Kwon, H. K. Chung, I. H. Kim, K. Ahn, E. J. Choi, I. Pastan, and M. Choe. 2001. A divalent recombinant immunotoxin formed by a disulfide bond between the extension peptide chains. Mol. Cells 12: 398-402.
17. Pastan, I., E. T. Lovelace, M. G. Gallo, A. V. Rutherford, J. L. Magnani, and M. C. Willingham. 1991. Characterization of monoclonal antibodies B1 and B3 that react with mucinous adenocarcinomas. Cancer Res. 51: 3781-3787.
18. Reiter, Y., U. Brinkmann, S. H. Jung, B. Lee, P. G. Kasprzyk, C. R. King, and I. Pastan. 1994. Improved binding and antitumor activity of a recombinant anti-erbB2 immunotoxin by disulfide stabilization of the Fv fragment. J. Biol. Chem. 269: 18327-18331.
19. Reiter, Y., L. H. Pai, U. Brinkmann, Q. C. Wang, and I. Pastan. 1994. Antitumor activity and pharmacokinetics in mice of a recombinant immunotoxin containing a disulfide-stabilized Fv fragment. Cancer Res. 54: 2714-2718.
20. Saito, T., R. J. Kreitman, S. Hanada, T. Makino, A. Utsunomiya, T. Sumizawa, et al. 1994. Cytotoxicity of recombinant Fab and Fv immunotoxins on adult T-cell leukemia lymph node and blood cells in the presence of soluble interleukin-2 receptor. Cancer Res. 54: 1059-1064.